title: Brentuximab vedotin: axonal microtubule's Apollyon.
authors: Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.
authors: S
authors: S
authors: Mariotto
authors: Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.
authors: S
authors: S
authors: Ferrari
authors: Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy.
authors: M
authors: M
authors: Sorio
authors: Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy.
authors: F
authors: F
authors: Benedetti
authors: School of Medicine, University of Verona, Verona, Italy.
authors: G
authors: G
authors: Tridente
authors: Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.
authors: T
authors: T
authors: Cavallaro
authors: Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.
authors: A
authors: A
authors: Gajofatto
authors: Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.
authors: S
authors: S
authors: Monaco
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D064592:Autografts; D000079963:Brentuximab Vedotin; D059248:Chemoradiotherapy; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D018796:Immunoconjugates / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000175:diagnosis*; D033581:Stem Cell Transplantation; D050257:Tubulin Modulators / Q000009:adverse effects* / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D018796:Immunoconjugates; D050257:Tubulin Modulators; D000079963:Brentuximab Vedotin